Kimmie Ng
Dana-Farber Cancer Institute · Academic and Community Cancer Research United
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kimmie Ng as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:23 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04094688 · Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal CancerAlliance for Clinical Trials in Oncology · active not recruiting · Colorectal Adenocarcinoma · study chair
- Ph2NCT02292758 · Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryAcademic and Community Cancer Research United · completed · Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 · principal investigator
- Early Ph1NCT02172651 · Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver MetastasesDana-Farber Cancer Institute · recruiting · Stage, Colon Cancer, Stage I-III Colon Cancer, Stage IV Colon Cancer With Resectable Liver Metastases · principal investigator
- Ph2NCT01516216 · Study of Vitamin D in Untreated Metastatic Colorectal CancerDana-Farber Cancer Institute · completed · Metastatic Colorectal Cancer · principal investigator
- Ph1/Ph2NCT00551421 · Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerNational Cancer Institute (NCI) · completed · Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor ImmunityR01CA205406 · NCI · DANA-FARBER CANCER INST · fiscal years 2017 to 2026 · $500,014 awarded in 2026Same name and institution; not confirmed by an ID
- Role of Vitamin D, Inflammation, and Energy Balance in Colorectal Cancer SurvivalK07CA148894 · NCI · DANA-FARBER CANCER INST · fiscal years 2011 to 2015 · $177,828 awarded in 2015Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2017 to 2026Named on NCT04094688
- Pathology Research Shared ResourceP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI THOMAS J FLOTTE · fiscal years 2016 to 2026Named on NCT02292758
- Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal CancerP50CA127003 · NCI · DANA-FARBER CANCER INST · PI NABEEL El-BARDEESY, WILLIAM R SELLERS · fiscal years 2016 to 2023Named on NCT02172651
- U01CA062490RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00551421
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:23 UTC. The ranking covers the 200 most relevant of 235 PubMed records, and a shared surname and initials can bring in a namesake. All 235 on PubMed
- A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.N Engl J Med · 19981,519 citationsRCR 45.1
- Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.Gastroenterology · 2000598 citationsRCR 16.0
- Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.Hepatology · 2001519 citationsRCR 14.8
- Factors influencing outcome following mild traumatic brain injury in adults.J Int Neuropsychol Soc · 2000430 citationsRCR 16.4
- Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.Oncologist · 2014326 citationsRCR 8.8
- 315 citationsRCR 11.6
- Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.Br J Surg · 2017270 citationsRCR 11.2
- A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.Clin Gastroenterol Hepatol · 2007231 citationsRCR 7.2
- Impact of early intervention on outcome after mild traumatic brain injury in children.Pediatrics · 2001229 citationsRCR 8.8
- 220 citationsRCR 18.8